Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin (2009)
- Autores:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.ejphar.2009.02.015
- Assuntos: ANGIOTENSINA II; SISTEMA CARDIOVASCULAR
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: European Journal of Pharmacology
- ISSN: 0014-2999
- Volume/Número/Paginação/Ano: v. 607, n. 1/3, p. 173-177, 2009
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MONTENEGRO, Marcelo Freitas e PESSA, Lisandra R. e SANTOS, José Eduardo Tanus dos. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin. European Journal of Pharmacology, v. 607, n. 1/3, p. 173-177, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2009.02.015. Acesso em: 25 set. 2024. -
APA
Montenegro, M. F., Pessa, L. R., & Santos, J. E. T. dos. (2009). Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin. European Journal of Pharmacology, 607( 1/3), 173-177. doi:10.1016/j.ejphar.2009.02.015 -
NLM
Montenegro MF, Pessa LR, Santos JET dos. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin [Internet]. European Journal of Pharmacology. 2009 ; 607( 1/3): 173-177.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.ejphar.2009.02.015 -
Vancouver
Montenegro MF, Pessa LR, Santos JET dos. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin [Internet]. European Journal of Pharmacology. 2009 ; 607( 1/3): 173-177.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.ejphar.2009.02.015 - Atorvastatina reduz a hipertensão arterial pulmonar causada por embolia pulmonar aguda (EPA) em ratos
- Enhanced concentrations of relevant markers of nitric oxide formation after exercise training in patients with metabolic syndrome
- Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble Fms-like tyrosine kinase-1 and soluble endogline in preeclampsia
- Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients
- Interethnic differences in the distribution of clinically relevant vascular endothelial growth factor genetic polymorphisms
- Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism
- Matrix metalloproteinase-9 genetic variation affect MMP-9 levels in obese children
- Sodium nitrite does not inhibit circulating angiotensin converting enzyme activity
- Matrix metalloproteinases as drug targets in preeclampsia
- Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension
Informações sobre o DOI: 10.1016/j.ejphar.2009.02.015 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas